What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActive

LOINC Code 81216-4: Progress note - recommended C-CDA R2.0 and R2.1 sections

Name: LOINC Code 81216-4: Progress note - recommended C-CDA R2.0 and R2.1 sections
Creator: HealthAssure Clinical Team
Published: 2026-05-21T09:00:05.774Z

81216-4 is a LOINC code used to identify Progress note - recommended C-CDA R2.0 and R2.1 sections in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Progress note - recommended C-CDA R2.0 & R2.1 sections. It is commonly used with the system or sample type {Setting}.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Progress note - recommended C-CDA R2.0 & R2.1 sections. It is commonly used with the system or sample type {Setting}.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Panel type: Convenience group

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

Progress note - recommended C-CDA R2.0 and R2.1 sections

Progress note - recommended C-CDA R2.0 & R2.1 sections

This panel contains the recommended sections for progress notes based on the HL7 Implementation Guide for CDA® Release 2Consolidated CDA Templates for Clinical Notes (US Realm) DSTU Releases 2.0 & 2.1.

Congenital dyserythropoietic anaemia; Encounter; Evaluation and management; Evaluation and management note; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Prog note; Prog note C-CDA R2.0+2.1 Sections; Random; subsequent evaluation; subsequent visit evaluation; Visit note

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Progress note - recommended C-CDA R2.0 and R2.1 sectionsProg note C-CDA R2.0+2.1 SectionsProgress note - recommended C-CDA R2.0 & R2.1 sectionsPANEL.DOC-Pt{Setting}

Frequently asked questions

Code details

Code81216-4

SystemLOINC

Display nameProgress note - recommended C-CDA R2.0 and R2.1 sections

DescriptionProgress note - recommended C-CDA R2.0 & R2.1 sections

Short nameProg note C-CDA R2.0+2.1 Sections

ComponentProgress note - recommended C-CDA R2.0 & R2.1 sections

Property-

TimingPt

System (specimen){Setting}

Scale-

ClassPANEL.DOC

StatusACTIVE

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.56

Last changed2.56

Part names

Progress note - recommended C-CDA R2.0 & R2.1 sections-Pt{Setting}Progress note - recommended C-CDA R2.0 and R2.1 sectionsPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.